Coniosetin, a novel tetramic acid antibiotic from Coniochaeta ellipsoidea DSM 13856.

J Antibiot (Tokyo)

Aventis Pharma Deutschland GmbH, Drug Innovation & Approval, Industriepark Höchst, D-65926 Frankfurt/Main, Germany.

Published: February 2003

The coprophilic ascomycete Coniochaeta ellipsoidea DSM 13856 forms the new antibiotic coniosetin (1) in surface cultures grown on a medium containing malt extract and oatmeal. The structure of the compound C25H35NO4, MW 413, was determined by 2D-NMR and mass spectrometric studies. Coniosetin belongs to the class of tetramic acids; it consists of a substituted aliphatic bicyclic ring system linked to a tetramic acid subunit through a carbonyl center. The absolute configuration was determined by measuring its circular dichroism spectrum and comparing the data with those of equisetin. Coniosetin has a pronounced antibacterial and antifungal action, inhibiting even multi drug-resistant strains of Staphylococcus aureus at a concentration of 0.3 microg/ml, though it is inactive against Gram-negative bacteria.

Download full-text PDF

Source
http://dx.doi.org/10.7164/antibiotics.56.114DOI Listing

Publication Analysis

Top Keywords

tetramic acid
8
coniochaeta ellipsoidea
8
ellipsoidea dsm
8
dsm 13856
8
coniosetin
4
coniosetin novel
4
novel tetramic
4
acid antibiotic
4
antibiotic coniochaeta
4
13856 coprophilic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!